SOLUTIONS

Delivering RNA-based solutions for your
disease early interception journey

Delivering RNA-based solutions for your disease early interception journey

Preventing Cancer Deaths Through Early Detection

We are saving lives with our flagship product, GASTROClear, the world’s first molecular blood test for early detection of gastric (stomach) cancer, the 4th deadliest cancer globally.

We are developing a multi-cancer screening test.

COVID-19 Response and Opportunities

We leveraged our expertise in RNA and PCR productization infrastructure to mass produce Singapore’s first and one of world’s first ten COVID-19 PCR tests.

Today, we offer a comprehensive range of infectious disease testing solutions.

Open Access to Personalized Testing

We seek to provide timely, actionable, and personalized insights to guide clinical decisions for every step of the patient journey

We are partnering healthcare institutions and payers to expand patient access to precision oncology testing services.

Copyright © 2024 MiRXES Pte Ltd. All rights reserved. | Privacy Policy
Scroll to Top